3 company-specific changes
fiscal period 2025-09-26
filed 2025-11-10
- Prior year disclosed ongoing BIS/DDTC investigations with $6M penalty and unquantified exposure. Current year removes all investigation details, suggesting resolution or closure of material regulatory matters.
- China exposure increased materially: manufacturing sites rose 18→19 and customer sales jumped 20%→25%, amplifying geopolitical and trade risk.
See the full detail →
19 company-specific changes
fiscal period 2025-10-03
filed 2025-11-07
- Proposed Qorvo merger introduces material risks: deal failure, regulatory uncertainty, substantial new debt, management distraction, and integration challenges. Reasonable investors would act on this.
- Material new risk: proposed $298.7M+ termination fees, regulatory/closing uncertainties, stock dilution, and significant transaction costs if Qorvo merger fails or delays.
See the full detail →
1 company-specific change
fiscal period 2025-09-30
filed 2025-11-06
- New explicit disclosure of litigation and investigation risk tied to CRS initiatives—anti-competitive, discriminatory, or unlawful allegations. Prior year lacked this specific legal exposure.
See the full detail →
6 company-specific changes
fiscal period 2025-09-28
filed 2025-11-05
- New explicit disclosure that Apple will increasingly use its own modem products rather than the company's products, with significant negative impact on QCT revenues and cash flows.
- Apple explicitly added as major customer vertically integrating; new language stating "significant negative impact" on QCT revenues and cash flows from Apple's modem transition.
See the full detail →
2 company-specific changes
fiscal period 2025-09-27
filed 2025-10-31
- New U.S. court order preventing App Store commissions on certain purchases; Google antitrust ruling and remedies threaten search licensing revenue; expanded global regulatory obligations; explicit stock price impact added.
- Removed mitigation language and added explicit consequence language. Shifted from "procedures will effectively limit" to "unable to monitor" creates heightened risk perception and potential operational/financial impact.
See the full detail →
2 company-specific changes
fiscal period 2025-08-31
filed 2025-10-10
- New DEI executive order compliance risk and GSA contract review initiative with documented adverse effects on AFS results and future operations.
- Added specific reference to "three-pronged talent strategy" initiated Q4 FY2025 and new H-1B visa risk, escalating restructuring and immigration concerns.
See the full detail →
17 company-specific changes
fiscal period 2025-08-28
filed 2025-10-03
- Multiple substantive escalations: China revenue dropped from ~50% to ~33%; new U.S. export restrictions disclosed; Taiwan production concentration risk newly emphasized as material.
- New disclosure of HBM capacity-shift risk: if HBM demand weakens, suppliers may shift capacity to conventional DRAM, causing oversupply and pricing pressure. Material competitive and financial risk.
See the full detail →
4 company-specific changes
fiscal period 2025-08-03
filed 2025-09-18
- New disclosure of actual tariff impacts on input costs (ingredients, packaging, tinplate steel) and finished goods. Concrete financial headwind with competitive disadvantage risk.
- Company escalated tariff risk from "moderate" 2024 to "more significant" 2026 cost pressures. Added finished product sourcing risk and explicit tariff impact disclosure.
See the full detail →
3 company-specific changes
fiscal period 2025-07-26
filed 2025-09-03
- Added specific tariff/trade tension risks, supplier delivery failures, fiscal 2025 purchase commitments for Cisco Silicon One, actual gross margin impacts, and $26M+ supplier settlement charge.
- New disclosure of litigation risk with specific 2025 settlement example showing material charge to cost of sales, indicating substantive legal exposure.
See the full detail →
2 company-specific changes
fiscal period 2025-07-31
filed 2025-09-03
- IRS free direct filing system moved from pilot (2024) to permanent (2025), escalating government competition threat to tax business revenue.
- Expanded target market from small businesses to small and mid-market businesses; changed business model from direct lending to loan purchasing, materially altering risk profile and capital requirements.
See the full detail →
12 company-specific changes
fiscal period 2025-07-31
filed 2025-08-29
- New material M&A risk: $1B termination fee, regulatory approval uncertainty, potential deal failure, and significant financial/reputational consequences disclosed for first time.
- New material acquisition risk: CyberArk deal introduces integration complexity, management distraction, competitive pressures, and synergy realization risk affecting combined company performance.
See the full detail →
1 company-specific change
fiscal period 2025-06-30
filed 2025-08-22
- Added specific pending transaction risk (Curtis Instruments acquisition) and explicit risk of failure to consummate announced deals, escalating from generic M&A risk.
See the full detail →
3 company-specific changes
fiscal period 2025-06-28
filed 2025-08-22
- Total indebtedness increased 11% ($12.0B to $13.3B). New disclosure of $1.75B near-term maturity and refinancing risk adds substantive liquidity concern.
- New UK Data Use and Access Act disclosure adds concrete localized data storage requirement and market segregation obligation, escalating compliance complexity and operational costs.
See the full detail →
12 company-specific changes
fiscal period 2025-06-30
filed 2025-08-15
- Material new risk: Amcor-Berry merger integration failure could disrupt operations, lose customers/talent, and prevent synergy realization. Newly disclosed post-close risk.
- New disclosure of substantial merger costs and integration risks. Material transaction and restructuring expenses, with uncertain timing and potential for synergies not to offset costs.
See the full detail →
11 company-specific changes
fiscal period 2025-06-27
filed 2025-08-14
- Separation completed; now faces post-spin risks: smaller/less diversified company, retained Sandisk equity stake, ongoing tax uncertainty, and execution challenges with material adverse effect potential.
- Post-Separation, Cloud end market now 88% of revenue; top 10 customers 68% of revenue with three at 10%+ each. Materially increased customer concentration and dependency risk.
See the full detail →
2 company-specific changes
fiscal period 2025-06-28
filed 2025-08-14
- Removal of material M&A risk. Capri Acquisition was blocked by FTC litigation; removal signals deal abandonment, eliminating regulatory, financing, and integration risks.
- New disclosure of active divestiture strategy with concrete example (Stuart Weitzman sale). Material strategic risk affecting operations, management focus, and shareholder value.
See the full detail →
12 company-specific changes
fiscal period 2025-06-30
filed 2025-08-12
- New disclosure of major opioid litigation, $650M+ settlement, ongoing private lawsuits, compliance costs, and reputational risk. Material legal and operational exposure.
- New disclosure of FDA warning letter (April 2024) for non-compliant syringes from Chinese supplier. Concrete regulatory enforcement action with operational and financial consequences.
See the full detail →
1 company-specific change
fiscal period 2025-06-29
filed 2025-08-11
- China revenue dropped from 42% to 34% year-over-year, signaling material adverse impact. New language about competitive position weakening escalates severity.
See the full detail →
3 company-specific changes
fiscal period 2025-06-30
filed 2025-08-08
- Venture wind-down announced; repurchase obligation reclassified to current liability (due Jan 2026); fair value declined to $476M but timing certainty increased near-term cash impact.
- New specific ERP implementation risks disclosed: system inefficiencies, integration challenges, data migration issues, security gaps, and operational disruptions with concrete timeline (FY2026 completion). Prior year was generic transformation language.
See the full detail →
4 company-specific changes
fiscal period 2025-06-30
filed 2025-08-08
- New 2024-2025 BIS Rules escalate restrictions on advanced DRAM and add entities to Entity List. China revenue declined from 43% to 33%. Actual harm to backlog now disclosed.
- New disclosure of April 2025 Chinese export controls on rare earth minerals critical to company's products, creating material supply chain disruption risk.
See the full detail →
18 company-specific changes
fiscal period 2025-06-30
filed 2025-08-08
- VirtuOx acquisition materially expands regulatory exposure: new IDTF Medicare/Medicaid obligations, Anti-Kickback Statute, False Claims Acts, HIPAA covered entity status, fraud/abuse risks, and compliance resource requirements.
- New disclosure of $3.2M settlement and five-year CIA with OIG for False Claims Act violations. Ongoing compliance costs and exclusion risk from federal healthcare programs materially impact operations and liquidity.
See the full detail →
4 company-specific changes
fiscal period 2025-06-30
filed 2025-08-07
- New disclosure of dual-class structure governance risk and institutional investor opposition, escalating capital structure concerns beyond prior dividend-only disclosure.
- New 2025 restructuring plan announced with additional headcount reduction. Prior plans substantially completed; escalation signals ongoing operational challenges and restructuring burden.
See the full detail →
2 company-specific changes
fiscal period 2025-06-30
filed 2025-08-06
- Total indebtedness decreased from $2.8B to $2.0B; Foxtel debt removed from Debtors group, reducing complexity and risk exposure materially.
- New disclosure of conflicting anti-ESG/anti-DEI legislation and specific litigation risks (defamation, libel, consumer protection) escalate regulatory and legal exposure.
See the full detail →
3 company-specific changes
fiscal period 2025-06-30
filed 2025-08-06
- Company disclosed actual $70M impairment charge on FCC licenses in fiscal 2025, escalating from generic risk disclosure to realized material loss.
- New regulatory threats: FCC February 2025 proceeding and July 2025 One Big Beautiful Bill Act directing C-Band spectrum auction within two years. Escalates spectrum loss risk beyond prior year's general discussion.
See the full detail →